9 results on '"Mohindra, Samir"'
Search Results
2. 13. Slow continuous infusion of diuretic, albumin and/or terlipressin (SAFI ± T) in patients with severe alcoholic hepatitis and acute on chronic liver failure.
3. 11. Slow albumin furosemide infusion with or without terlipressin and noradrenalin (SAFIT NA) improves 28 days survival in acute-on-chronic liver failure (ACLF) than standard medical therapy.
4. 17. Impact of alteration in hemodynamics and intestinal permeability in acute on chronic liver failure.
5. Slow Infusion of Furosemide and Albumin With or Without Terlipressin in Acute on Chronic Liver Failure Patients With Organ Failure(s): Safety and Efficacy in Ascites Mobilization and Effect on 28 Day Survival.
6. Slow Low-Dose Continuous Albumin, Furosemide ± Terlipressin SIFA(±T) With N-acetycystine (NAC) Infusion in Severe Alcoholic Hepatitis (SAH)-Acute-On-Chronic Liver Failure (ACLF) With Organ Failure(S) Safely Mobilizes Ascites and Improves 28-Day Survival
7. Slow, Continuous Low-Dose Albumin and Furosemide Infusion (SCLAFI) With/Without Terlipressin Mobilizes Refractory Ascites Safely in Decompensated Liver Cirrhosis.
8. Assess 28-Day Survival of Top Down Approach of Slow Low-Dose Continuous Albumin + Furosemide ± Terlipressin (SAFI ± T) and N-Acetycystine Infusion and Probiotics in ACLF Patients with MELD ≥ 35, Ascites and High CVP (Central Venous Pressure) ± Organ Failure
9. Slow, Continuous Low-Dose Albumin and Furosemide Infusion (SCLAFI) Mobilizes Large Ascites Safely in Decompensated Liver Cirrhosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.